[FG] Schaub Stefan

Diebold, M. and Sharif, A. (2025) ‘Breaking barriers: giving HOPE to people living with HIV and end-stage renal disease’, Clinical Kidney Journal [Preprint]. Available at: https://doi.org/10.1093/ckj/sfaf027.

Lombardi, Y. et al. (2024) ‘Estimating the efficacy of felzartamab to treat antibody-mediated rejection using the iBox prognostication system’, American Journal of Transplantation [Preprint]. Available at: https://doi.org/10.1016/j.ajt.2024.12.004.

Halloran, P. et al. (2024) ‘Effect of felzartamab anti-CD38 treatment on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies.’ Springer Science and Business Media LLC. Available at: https://doi.org/10.21203/rs.3.rs-4870641/v1.

Diebold, M. et al. (2024) ‘Natural Killer Cell Presence in Antibody-Mediated Rejection’, Transplant International, 37. Available at: https://doi.org/10.3389/ti.2024.13209.

Mayer, K.A. et al. (2024) ‘A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection’, New England Journal of Medicine [Preprint]. Available at: https://doi.org/10.1056/nejmoa2400763.

Diebold, M. et al. (2024) ‘Natural killer cell functional genetics and donor-specific antibody-triggered microvascular inflammation’, American Journal of Transplantation, 24(5), pp. 743–754. Available at: https://doi.org/10.1016/j.ajt.2023.12.005.

Hirt-Minkowski, P. and Schaub, S. (2024) ‘Urine CXCL10 as a biomarker in kidney transplantation’, Current Opinion in Organ Transplantation, 29(2), pp. 138–143. Available at: https://doi.org/10.1097/mot.0000000000001135.

Hirt-Minkowski, Patricia, Wehmeier, Caroline and Schaub, Stefan (2023) ‘Authors” Reply: Of End Points and Context of Use: A Reasonable Silver Lining for Urinary Chemokines Monitoring’, Journal of the American Society of Nephrology, 34(10), pp. 1766–1767. Available at: https://doi.org/10.1681/ASN.0000000000000205.

Hug, Melanie N. et al. (2023) ‘HLA antibody affinity determination: From HLA-specific monoclonal antibodies to donor HLA specific antibodies (DSA) in patient serum’, HLA, 102(3), pp. 278–300. Available at: https://doi.org/10.1111/tan.15047.

Ho, Julie et al. (2023) ‘Multicenter Validation of a Urine CXCL10 Assay for Noninvasive Monitoring of Renal Transplants’, Transplantation, 107(7), pp. 1630–1641. Available at: https://doi.org/10.1097/TP.0000000000004554.

Schwab, S. et al. (2023) ‘Clinical prediction model for prognosis in kidney transplant recipients (KIDMO): study protocol’, Diagnostic and Prognostic Research, 7(1). Available at: https://doi.org/10.1186/s41512-022-00139-5.

de Rougemont, Olivier et al. (2023) ‘Donation type and the effect of pre-transplant donor specific antibodies – Data from the Swiss Transplant Cohort Study’, Frontiers in Immunology, 14. Available at: https://doi.org/10.3389/fimmu.2023.1104371.

Frischknecht, Lukas et al. (2022) ‘The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation – Data from the Swiss transplant cohort study’, Frontiers in Immunology, 13. Available at: https://doi.org/10.3389/fimmu.2022.1005790.

Dirchwolf, M. et al. (2022) ‘The MELD upgrade exception: a successful strategy to optimize access to liver transplantation for patients with high waiting list mortality’, HPB, 24(7), pp. 1168–1176. Available at: https://doi.org/10.1016/j.hpb.2021.12.009.

Bräutigam M et al. (2022) ‘Frequency, reactivity and evolution of human leukocyte antigen and human platelet antigen antibodies in the setting of hematopoietic cell transplantation’, Transfusion and Apheresis Science, 61(2), p. 103301. Available at: https://doi.org/10.1016/j.transci.2021.103301.

Kuhn C. et al. (2022) ‘Relevance of deceased donor proteinuria for kidney transplantation: A comprehensive national cohort study’, Clinical Transplantation, 36(4). Available at: https://doi.org/10.1111/ctr.14574.

Schreiber, P.W. et al. (2022) ‘Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study’, Journal of Hospital Infection, 128, pp. 47–53. Available at: https://doi.org/10.1016/j.jhin.2022.07.009.

Niemann M et al. (2021) ‘Peptides Derived From Mismatched Paternal Human Leukocyte Antigen Predicted to Be Presented by HLA-DRB1, -DRB3/4/5, -DQ, and -DP Induce Child-Specific Antibodies in Pregnant Women’, Frontiers in Immunology, 12, p. 797360. Available at: https://doi.org/10.3389/fimmu.2021.797360.

Julen K. et al. (2021) ‘Transfusions in Aplastic Anemia Patients Cause HLA Alloimmunization: Comparisons of Current and Past Cohorts Demonstrate Progress’, Transplantation and Cellular Therapy, 27(11), p. 939.e1–939.e8. Available at: https://doi.org/10.1016/j.jtct.2021.07.017.

Ingold L. et al. (2021) ‘Short- and long-term impact of neutropenia within the first year after kidney transplantation’, Transplant International, 34(10), pp. 1875–1885. Available at: https://doi.org/10.1111/tri.13976.

Schweiger, M. et al. (2021) ‘Use of induction therapy in pediatric heart transplant recipients in Switzerland – Analysis of the Swiss national database’, Transplant Immunology, 68. Available at: https://doi.org/10.1016/j.trim.2021.101443.

Handschin J et al. (2021) ‘Urinary CXCL10 Measurement in Late Renal Allograft Biopsies Predicts Outcome Even in Histologically Quiescent Patients’, Transplantation Proceedings, 53(7), pp. 2168–2179. Available at: https://doi.org/10.1016/j.transproceed.2021.07.013.

Senn L et al. (2021) ‘Outcome of Husband-to-Wife Kidney Transplantation With Mutual Children: Single Center Experience Using T Cell-Depleting Induction and Review of the Literature’, Frontiers in Medicine, 8, p. 724851. Available at: https://doi.org/10.3389/fmed.2021.724851.

Diebold M et al. (2021) ‘Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study’, Swiss Medical Weekly, 151(29-30), p. w20572. Available at: https://doi.org/10.4414/smw.2021.20572.

Diebold M et al. (2021) ‘Comparison of acute kidney injury in patients with covid-19 and other respiratory infections: A prospective cohort study’, Journal of Clinical Medicine, 10(11). Available at: https://doi.org/10.3390/jcm10112288.

Kuhn C. et al. (2021) ‘Outcome of kidney transplantation from very senior donors in Switzerland – a national cohort study’, Transplant International, 34(4), pp. 689–699. Available at: https://doi.org/10.1111/tri.13836.

Perrottet N et al. (2021) ‘Infectious complications and graft outcome following treatment of acute antibodymediated rejection after kidney transplantation: A nationwide cohort study’, PLoS ONE, 16(4 April), p. e0250829. Available at: https://doi.org/10.1371/journal.pone.0250829.

Diebold M et al. (2021) ‘Acute kidney injury in patients with COVID-19: A retrospective cohort study from Switzerland’, Swiss Medical Weekly, 151(9), p. w20482. Available at: https://doi.org/10.4414/smw.2021.20482.

Cun H et al. (2021) ‘Screening strategy for de novo donor-specific HLA antibodies beyond the first year after kidney transplantation: Personalized or “one size fits all”?’, Clinical Transplantation, 35(2), p. e14170. Available at: https://doi.org/10.1111/ctr.14170.

Bonani M et al. (2021) ‘Dialysis after graft loss: A Swiss experience’, Nephrology Dialysis Transplantation, 35(12), pp. 2182–2190. Available at: https://doi.org/10.1093/NDT/GFAA037.

Schawalder L et al. (2021) ‘Development of an immunogenicity score for HLA-DQ eplets: A conceptual study’, HLA, 97(1), pp. 30–43. Available at: https://doi.org/10.1111/tan.14110.

Stampf, Susanne et al. (2021) ‘Cohort profile: The Swiss Transplant Cohort Study (STCS): A nationwide longitudinal cohort study of all solid organ recipients in Switzerland’, BMJ Open, 11(12), p. e051176. Available at: https://doi.org/10.1136/bmjopen-2021-051176.

Wehmeier, Caroline et al. (2021) ‘Pre-transplant donor-specific HLA antibodies and risk for poor first-year renal transplant outcomes: results from the Swiss Transplant Cohort Study’, Transplant International, 34, pp. 2755–2768. Available at: https://doi.org/10.1111/tri.14119.

Hönger G et al. (2020) ‘Toward defining the immunogenicity of HLA epitopes: Impact of HLA class I eplets on antibody formation during pregnancy’, HLA, 96(5), pp. 589–600. Available at: https://doi.org/10.1111/tan.14054.

Bischof N et al. (2020) ‘Revisiting cytomegalovirus serostatus and replication as risk factors for inferior long-term outcomes in the current era of renal transplantation’, Nephrology Dialysis Transplantation, 35(2), pp. 346–356. Available at: https://doi.org/10.1093/ndt/gfz268.

Handschin J et al. (2020) ‘Technical Considerations and Confounders for Urine CXCL10 Chemokine Measurement’, Transplantation Direct, 6(1), p. e519. Available at: https://doi.org/10.1097/TXD.0000000000000959.

Wehmeier, Caroline et al. (2020) ‘Donor-specific B Cell Memory in Alloimmunized Kidney Transplant Recipients: First Clinical Application of a Novel Method’, Transplantation, 104(5), pp. 1026–1032. Available at: https://doi.org/10.1097/tp.0000000000002909.

Wehmeier C, Hönger G and Schaub S (2020) ‘Caveats of HLA antibody detection by solid-phase assays’, Transplant International, 33(1), pp. 18–29. Available at: https://doi.org/10.1111/tri.13484.

Leuzinger K. et al. (2019) ‘Quantification of plasma BK polyomavirus loads is affected by sequence variability, amplicon length, and non-encapsidated viral DNA genome fragments’, Journal of Clinical Virology, 121. Available at: https://doi.org/10.1016/j.jcv.2019.104210.

Spica D et al. (2019) ‘Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation’. S. Karger AG, 9(3). Available at: https://doi.org/10.1159/000503951.

Bischof N et al. (2019) ‘Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: Long-term outcomes’, Nephrology Dialysis Transplantation, 34(7), pp. 1240–1250. Available at: https://doi.org/10.1093/ndt/gfy346.

Schaub S, Immer F and Steiger J (2019) ‘Organ Transplantation in Switzerland’, Transplantation, 103(5), pp. 853–855. Available at: https://doi.org/10.1097/TP.0000000000002565.

Trefny MP et al. (2019) ‘A variant of a killer cell immunoglobulin-like receptor is associated with resistance to PD-1 blockade in lung cancer’, Clinical Cancer Research, 25(10), pp. 3026–3034. Available at: https://doi.org/10.1158/1078-0432.ccr-18-3041.

Ersözlü S et al. (2018) ‘Long-term Outcomes of Kidney Transplantation in Fabry Disease.’, Transplantation, 102(11), pp. 1924–1933. Available at: https://doi.org/10.1097/tp.0000000000002252.

Naegele K et al. (2018) ‘Cytomegalovirus sequence variability, amplicon length, and DNase-sensitive non-encapsidated genomes are obstacles to standardization and commutability of plasma viral load results.’, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 104, pp. 39–47. Available at: https://doi.org/10.1016/j.jcv.2018.04.013.

Arnold ML et al. (2018) ‘Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival.’, International journal of immunogenetics. 25.03.2018, 45(3), pp. 95–101. Available at: https://doi.org/10.1111/iji.12363.

Bouquegneau A et al. (2018) ‘Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.’, PLoS medicine, 15(5), p. e1002572. Available at: https://doi.org/10.1371/journal.pmed.1002572.

Ho J et al. (2018) ‘Urinary CXCL10 Chemokine Is Associated With Alloimmune and Virus Compartment-Specific Renal Allograft Inflammation.’, Transplantation, 102(3), pp. 521–529. Available at: https://doi.org/10.1097/tp.0000000000001931.

Wehmeier C et al. (2018) ‘Successful steroid withdrawal guided by surveillance biopsies-A single-center experience.’, Clinical transplantation, 32(3), p. e13181. Available at: https://doi.org/10.1111/ctr.13181.

Nickeleit V et al. (2018) ‘The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations.’, Journal of the American Society of Nephrology : JASN, 29(2), pp. 680–693. Available at: https://doi.org/10.1681/asn.2017050477.

Valenzuela NM and Schaub S (2018) ‘The Biology of IgG Subclasses and Their Clinical Relevance to Transplantation.’, Transplantation, 102(1S Suppl 1), pp. S7–S13. Available at: https://doi.org/10.1097/tp.0000000000001816.

Hönger G et al. (2017) ‘Effects of weak/non-complement-binding HLA antibodies on C1q-binding.’, HLA. 05.06.2017, 90(2), pp. 88–94. Available at: https://doi.org/10.1111/tan.13062.

Wehmeier C et al. (2017) ‘Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients.’, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 17(8), pp. 2092–2102. Available at: https://doi.org/10.1111/ajt.14247.

Reiher, Viktoria S A et al. (2017) ‘Human platelet antigen antibody induction in uncomplicated pregnancy is associated with HLA sensitization.’, 57(5). Available at: https://doi.org/10.1111/trf.14053.

Hirsch, H. et al. (2017) ‘BK Polyomavirus-Specific 9mer T-Cell Responses Predict Control of Viremia in Kidney Transplant Recipients: First Report from the Swiss Transplant Cohort Study’. WILEY, 17.

Wehmeier C et al. (2017) ‘Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis.’, Transplantation direct, 3(3), p. e136. Available at: https://doi.org/10.1097/txd.0000000000000650.

Kim MJ et al. (2016) ‘Effect of immunosuppressive drugs on the changes of serum galactose-deficient IgA1 in patients with IgA nephropathy’, PLoS ONE, 11(12). Available at: https://doi.org/10.1371/journal.pone.0166830.

Duquesnoy RJ et al. (2016) ‘Antibody-defined epitopes on HLA-DQ alleles reacting with antibodies induced during pregnancy and the design of a DQ eplet map’, Human Immunology, 77(10), pp. 824–831. Available at: https://doi.org/10.1016/j.humimm.2016.06.021.

Hirt-Minkowski P et al. (2016) ‘Six-month urinary CCL2 and CXCL10 levels predict long-term renal allograft outcome’, Transplantation, 100(9), pp. 1988–1996. Available at: https://doi.org/10.1097/tp.0000000000001304.

Duquesnoy RJ et al. (2016) ‘Detection of newly antibody-defined epitopes on HLA class I alleles reacting with antibodies induced during pregnancy.’, International journal of immunogenetics. 16.06.2016, 43(4), pp. 200–8. Available at: https://doi.org/10.1111/iji.12280.

Golshayan, Déla et al. (2016) ‘Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation’, Kidney International, 89(4), pp. 927–938. Available at: https://doi.org/10.1016/j.kint.2015.11.025.

Duquesnoy RJ et al. (2016) ‘Identification of epitopes on HLA-DRB alleles reacting with antibodies in sera from women sensitized during pregnancy’, Human Immunology, 77(2), pp. 214–222. Available at: https://doi.org/10.1016/j.humimm.2015.12.002.

Burkhalter, F. et al. (2016) ‘A Comparison of Two Types of Rabbit Antithymocyte Globulin Induction Therapy in Immunological High-Risk Kidney Recipients: A Prospective Randomized Control Study’, PLoS ONE, 11(11), p. e0165233. Available at: https://doi.org/10.1371/journal.pone.0165233.

Drexler, Beatrice et al. (2016) ‘Impact of donor ABH-secretor status in ABO-mismatched living donor kidney transplantation’, Transfusion, 56(9), pp. 2355–61. Available at: https://doi.org/10.1111/trf.13711.

Geneugelijk K et al. (2016) ‘A Previous Miscarriage and a Previous Successful Pregnancy Have a Different Impact on HLA Antibody Formation during a Subsequent Successful Pregnancy.’, Frontiers in immunology, 7, p. 571. Available at: https://doi.org/10.3389/fimmu.2016.00571.

Geneugelijk K et al. (2015) ‘Predicted Indirectly Recognizable HLA Epitopes Presented by HLA-DRB1 Are Related to HLA Antibody Formation During Pregnancy.’, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 29.10.2015, 15(12), pp. 3112–22. Available at: https://doi.org/10.1111/ajt.13508.

Hirt-Minkowski P et al. (2015) ‘Prediction of Long-term Renal Allograft Outcome By Early Urinary CXCL10 Chemokine Levels.’, Transplantation direct. 24.09.2015, 1(8), p. e31. Available at: https://doi.org/10.1097/txd.0000000000000537.

Amico P and Schaub S (2015) ‘Donor-specific HLA-antibodies: the difficulty of separating the wheat from the chaff.’, 15(4). Available at: https://doi.org/10.1111/ajt.13156.

Burger, Bettina et al. (2015) ‘Risk of Cutaneous Squamous Cell Carcinoma Development in Renal Transplant Recipients Is Independent of TMC/EVER Alterations’, Dermatology, 231(3), pp. 245–52. Available at: https://doi.org/10.1159/000435910.

Egli, A. et al. (2015) ‘Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) directly from positive blood culture flasks allows rapid identification of bloodstream infections in immunosuppressed hosts’, Transpl Infect Dis, 17(3), pp. 481–7. Available at: https://doi.org/10.1111/tid.12373.

Hönger, G. et al. (2015) ‘Inter-individual differences in HLA expression can impact the CDC crossmatch’, Tissue Antigens, 85(4), pp. 260–6. Available at: https://doi.org/10.1111/tan.12537.

Schaub S et al. (2014) ‘Determinants of C1q binding in the single antigen bead assay.’, Transplantation, 98(4), pp. 387–93. Available at: https://doi.org/10.1097/tp.0000000000000203.

Hönger G et al. (2014) ‘Human pregnancy and generation of anti-angiotensin receptor and anti-perlecan antibodies’, Transplant International, 27(5), pp. 467–474. Available at: https://doi.org/10.1111/tri.12282.

Praehauser C et al. (2013) ‘Risk factors and outcome of expanded-criteria donor kidney transplants in patients with low immunological risk’, Swiss Medical Weekly. 12.11.2013, 143, p. w13883. Available at: https://doi.org/10.4414/smw.2013.13883.

Suesal, C. et al. (2013) ‘Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients’, TISSUE ANTIGENS. WOS.SCI, 82, pp. 83–92. Available at: https://doi.org/10.1111/tan.12137.

Hönger G et al. (2013) ‘Frequency and determinants of pregnancy-induced child-specific sensitization.’, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 11.01.2013, 13(3), pp. 746–53. Available at: https://doi.org/10.1111/ajt.12048.

Arnold ML et al. (2013) ‘16(th) IHIW: anti-HLA alloantibodies of the of IgA isotype in re-transplant candidates.’, International journal of immunogenetics. 22.12.2012, 40(1), pp. 17–20. Available at: https://doi.org/10.1111/iji.12032.

Hirt-Minkowski P et al. (2013) ‘Soluble CD30 correlates with clinical but not subclinical renal allograft rejection’, Transplant International. 08.11.2012, 26(1), pp. 75–83. Available at: https://doi.org/10.1111/j.1432-2277.2012.01578.x.

Menter, T. et al. (2013) ‘Pathology of Resolving Polyomavirus-Associated Nephropathy’, American journal of transplantation, 13(6), pp. 1474–1483. Available at: https://doi.org/10.1111/ajt.12218.

Schaub S and Hirt-Minkowski P (2013) ‘Urinary-cell mRNA and acute kidney-transplant rejection [1]’, New England Journal of Medicine, 369(19), pp. 1858–1861. Available at: https://doi.org/10.1056/NEJMc1310006.

Hirt-Minkowski P et al. (2012) ‘Delayed graft function is not associated with an increased incidence of renal allograft rejection’, Clinical Transplantation. 29.10.2012, 26(6), pp. E624–33. Available at: https://doi.org/10.1111/ctr.12041.

Hirt-Minkowski P et al. (2012) ‘Detection of clinical and subclinical tubulo-interstitial inflammation by the urinary CXCL10 chemokine in a real-life setting’, American Journal of Transplantation, 12(7), pp. 1811–1823. Available at: https://doi.org/10.1111/j.1600-6143.2012.03999.x.

Burkhalter F, Schaub S and Dickenmann M (2012) ‘Preserved circannual rhythm of vitamin D in kidney transplant patients’, Swiss Medical Weekly. 04.09.2012, 142, p. w13672. Available at: https://doi.org/10.4414/smw.2012.13672.

Amico, Patrizia et al. (2011) ‘Risk stratification by the virtual crossmatch : a prospective study in 233 renal transplantations’, Transplant international, 24(6), pp. 560–9. Available at: https://doi.org/10.1111/j.1432-2277.2011.01235.x.

Bray, R. A., Murphey, C. and Schaub, S. (2011) ‘Calculated PRA : a process whose time has come or “Déjà vu” all over again?’, American journal of transplantation, 11(4), pp. 650–651. Available at: https://doi.org/10.1111/j.1600-6143.2011.03452.x.

Durovic, B et al. (2011) ‘Allo-induced acute-phase response : IL-6 identifies a subset of individuals at risk for graft injury’, Scandinavian journal of immunology, 73(2), pp. 156–8. Available at: https://doi.org/10.1111/j.1365-3083.2010.02489.x.

Hönger, Gideon et al. (2011) ‘Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection’, Transplantation, 92(1), pp. 41–7. Available at: https://doi.org/10.1097/tp.0b013e31821cdf0d.

Bächler, K et al. (2010) ‘Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low-level donor-specific HLA-antibodies’, American journal of transplantation, 10(5), pp. 1254–62. Available at: https://doi.org/10.1111/j.1600-6143.2010.03093.x.

Hönger, Gideon et al. (2010) ‘C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection’, Transplantation, 89(12), pp. 1471–5. Available at: https://doi.org/10.1097/tp.0b013e3181dc13e7.

Schaub, S et al. (2010) ‘Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy’, American journal of transplantation, 10(12), pp. 2615–23. Available at: https://doi.org/10.1111/j.1600-6143.2010.03310.x.

Berben L et al. (2009) ‘Prevalence and correlates of influenza vaccination among kidney transplant patients’, Progress in Transplantation, 19(4), pp. 312–317. Available at: https://doi.org/10.1177/152692480901900405.

Amico, Patrizia et al. (2009) ‘Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads’, Transplantation : official journal of the Transplantation Society, 87(11), pp. 1681–8. Available at: https://doi.org/10.1097/tp.0b013e3181a5e034.

Amico, Patrizia et al. (2009) ‘Utility of the virtual crossmatch in solid organ transplantation’, Current opinion in organ transplantation, 14(6), pp. 656–61. Available at: https://doi.org/10.1097/mot.0b013e328331c169.

Hirt-Minkowski, Patricia et al. (2009) ‘Haemolytic uraemic syndrome caused by factor H mutation : is single kidney transplantation under intensive plasmatherapy an option?’, Nephrology, dialysis, transplantation, 24(11), pp. 3548–51. Available at: https://doi.org/10.1093/ndt/gfp377.

Provenzano, Maurizio et al. (2009) ‘A HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities’, Journal of cellular and molecular medicine : an international journal, 13(8B), pp. 2131–47. Available at: https://doi.org/10.1111/j.1582-4934.2008.00531.x.

Schaub, S et al. (2009) ‘Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis’, American journal of transplantation : official journal of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST), 9(6), pp. 1347–53. Available at: https://doi.org/10.1111/j.1600-6143.2009.02645.x.

Zenhaeusern, G et al. (2009) ‘CD56(bright) natural killer cells expand and contract irrespective of CD25 antibody treatment in kidney allograft recipients’, Scandinavian journal of immunology, 69(5), pp. 465–7. Available at: https://doi.org/10.1111/j.1365-3083.2009.02236.x.

Amico P et al. (2008) ‘Detection of HLA antibodies prior to renal transplantation: prospects and limitations of new assays’, Swiss Medical Weekly, 138(33-34), pp. 472–476. Available at: https://doi.org/10.4414/smw.2008.12272.

Descoeudres B et al. (2008) ‘Contribution of early failure to outcome on peritoneal dialysis.’, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 28(3), pp. 259–67.

Amico, Patrizia et al. (2008) ‘Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies’, Transplantation, 85(11), pp. 1557–63. Available at: https://doi.org/10.1097/tp.0b013e31816f612a.